Alyssa Cornall
Research Officer
Infection and Immunity
Murdoch Childrens Research Institute
Australia
Biography
Dr Alyssa Cornall was awarded a PhD in biochemistry from Monash University/Burnet Institute in 2007 for research into virus-host interactions of HIV-1, and went on to develop an assay for predicting susceptibility of patient HIV isolates to entry inhibitors based on their leukocyte co-receptor usage. Following this, she spent three years in Darwin, Northern Territory on an Australian Research Council (ARC) funded project investigating the effects of industrial metals exposure on the microbial community of tropical coastal sediments and their potential use as biomarkers of ecosystem health. Since 2012, Dr Cornall have been using cutting-edge molecular techniques to investigate the natural history and epidemiology of human papillomavirus (HPV) related to development of anogenital cancers at the Royal Women's Hospital/Royal Children's Hospital molecular biology laboratory.
Research Interest
Molecular Microbiology
Publications
-
Cornall AM, Quint WH, Garland SM, Tabrizi SN. Evaluation of an automated SPF10-LiPA25 assay for detection and typing of human papillomavirus in archival samples. Journal of virological methods. 2014 Apr 30;199:116-8.
-
Zou H, Tabrizi SN, Grulich AE, Garland SM, Hocking JS, Bradshaw CS, Morrow A, Prestage G, Cornall AM, Fairley CK, Chen MY. Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. The Journal of infectious diseases. 2013 Nov 21;209(5):642-51.
-
Cornall A, Mak J, Greenway A, Tachedjian G. HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenon. Viruses. 2013 Sep 18;5(9):2235-52.
